Anti-Covid vaccines updated to Omicron towards the green light in the EU. The extraordinary meeting of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency Ema is scheduled for Thursday 1 September to discuss the authorization requests submitted by Moderna and Pfizer / BioNTech, for bivalent mRna vaccines. , adapted to cover the Omicron BA.1 sub-variant and the original Sars-Cov-2 strain. “The purpose of the meeting is to conclude, if possible, the evaluation of the two questions”, explains the EMA announcing the appointment of 1 September.
#Covid #vaccines #updated #Ema #green #light #September